Benzinga··Im Cannabis CorpIM Cannabis Raises $550K via Convertible Notes to Fund Operations
IM Cannabis ($IMCC) closes convertible note financing totaling $550,000 in gross proceeds to support general corporate purposes.
IMCCfinancingwarrants
warrants
27 articlesBenzinga··Im Cannabis Corp
GlobeNewswire Inc.··NaBrazil Potash Raises $63.3M to Accelerate Amazon Potash Mining Project
Brazil Potash ($GRO) closes $63.3M offering to fund Amazon potash development, raising capital through share issuance and warrants for project advancement.
GROwarrantspublic offering
Benzinga··NaEast Side Games Raises $3.5M Via Private Placement to Pay Down Debt
East Side Games Group ($EAGR) raises $3.5M through private placement at $0.11 per unit, with insider Derek Lew investing $1M to support turnaround strategy.
RYprivate placementwarrants
GlobeNewswire Inc.··NaHall Chadwick Acquisition Corp II Seeks $265M Nasdaq IPO to Fund Strategic SPAC Deals
Blank check company Hall Chadwick Acquisition Corp II filed for $265M Nasdaq IPO, targeting business combinations in connectivity, sustainability, and infrastructure sectors.
COHNHCACHCACRHCACUIPOinfrastructure
Benzinga··Globe NewswireAuddia Raises $12M in Public Offering to Fuel Growth Initiatives
Auddia raises $12M in public offering, selling 5.08M shares at $2.36 per share. Capital designated for working capital and corporate initiatives.
AUUDwarrantspublic offering
Benzinga··Globe NewswireAuddia Taps Capital Markets with $12M Offering Ahead of 2026 Close
Auddia priced $12M public offering at $2.36/share, consisting of 5.1M shares and warrants, closing April 2026.
AUUDwarrantspublic offering
GlobeNewswire Inc.··NaAltimmune Raises $225M in Oversubscribed Offering to Fund MASH Trial
Altimmune raises $225M in oversubscribed offering to fund Phase 3 MASH trial, pricing 64.25M shares at $3.00 each.
ALTwarrantspublic offering
GlobeNewswire Inc.··NaBavarian Nordic Shareholders Reject Compensation Report at 2026 AGM
Bavarian Nordic held its annual meeting April 21, approving 2025 results and expanding the board to seven members, but shareholders rejected the compensation report in non-binding vote.
BVNRYwarrantsAnnual General Meeting
GlobeNewswire Inc.··Giga Metals Corp.Giga Metals Raises C$1M via Private Placement for BC Nickel Project
Giga Metals raises C$1M via private placement at C$0.08/unit for Turnagain nickel-cobalt project in British Columbia, with closing expected May 2026.
MTSUYprivate placementfinancing
GlobeNewswire Inc.··Not SpecifiedPhilippines Waste Recycler YDDL Closes $13M Offering, Expands Capital Base
One and One Green Technologies closed $13M follow-on offering at $7.50/unit. Company raises capital for working capital and operations.
YDDLinstitutional investorswarrants
Benzinga··NaVireo Growth Acquires Hawthorne Gardening from Scotts in $110M Recapitalization Deal
Vireo Growth completes Hawthorne Gardening acquisition from Scotts Miracle-Gro, gaining $110M in cash and working capital through equity issuance.
SMGacquisitionwarrants
GlobeNewswire Inc.··Univest Securities, LlcUnivest Closes $16M Offering for Wire Harness Maker Linkers Industries
Univest Securities closed a $16 million public offering for wire harness maker Linkers Industries, raising capital for acquisitions and operations.
LNKSwarrantspublic offering
Benzinga··Globe NewswireEV Maker LOBO Prices $2M Public Offering to Fund Development
LOBO Technologies prices $2M public offering of 3.9M units at $0.51 each, with proceeds for EV development and working capital.
LOBOwarrantspublic offering
Benzinga··Not SpecifiedOutlook Therapeutics Launches Capital Raise Through Public Stock Offering
Outlook Therapeutics launches best-efforts public offering of stock and warrants with H.C. Wainwright as placement agent, subject to market conditions.
OTLKwarrantspublic offering
Benzinga··Globe NewswireReviva Pharmaceuticals Closes $10M Offering to Fund Schizophrenia Drug Trial
Reviva Pharmaceuticals closed a $10M public offering at $1.50/share to fund its RECOVER-2 Phase 3 schizophrenia trial, maintaining $23M cash through Q1 2027.
RVPHwarrantspublic offering
GlobeNewswire Inc.··NaNyxoah SA Reports 10.14% Stake Crossing via Transparency Notification
Nyxoah SA disclosed that Robert Taub and Robelga SRL exceeded 3% voting threshold in December 2025, holding 10.14% combined stake.
NYXHvoting rightswarrants
Benzinga··Globe NewswireReviva Pharma Raises $10M via Public Offering to Fund Schizophrenia Drug Trial
Reviva Pharma raises $10M via share offering priced at $1.50 per share to fund Phase 3 schizophrenia drug trial through March 2026 closing.
RVPHwarrantspublic offering
GlobeNewswire Inc.··NaReviva Pharma Raises $10M via Public Offering to Fund Schizophrenia Drug Trial
Reviva Pharmaceuticals prices $10M offering at $1.50/share to fund brilaroxazine Phase 3 schizophrenia trial and operations.
RVPHwarrantspublic offering
GlobeNewswire Inc.··NaQuantum BioPharma Adjusts Debenture Terms Amid Share Price Decline
Quantum BioPharma revises debenture offering terms following share price decline, lowering conversion price to $3.00 and increasing warrant allocation.
QNTMwarrantsbiopharmaceutical
GlobeNewswire Inc.··Bioxcel Therapeutics, Inc.BioXcel Therapeutics Raises $8M via Direct Offering Amid Market Challenges
BioXcel Therapeutics raises $8M via direct offering of 4.5M shares at $1.739/share, with warrant modifications agreed, closing expected March 2026.
BTAIartificial intelligencewarrants